Meridian Revogene® GBS DS
A precise diagnostic test for qualitative detection of Group B Streptococcus (GBS) from vaginal or rectal swabs obtained from pregnant women. The real-time polymerase chain reaction (PCR) is detecting a cfb gene sequence that is specific to the Streptococcus agalactiae genome.
General information
The Meridian Revogene® GBS assay enables healthcare professionals to detect the presence of Group B Streptococcus (GBS) within 70 minutes. The assay provides physicians with accurate and reliable results, allowing for appropriate treatment decisions of the mother at the time of delivery, ensuring the best outcome for the baby.
Well documented method with excellent performance
- Based on well-established and widely used molecular method (real-time PCR)
- Performance correlates with the reference methods
Technical information
| Available product |
|
| Method | Polymerase chain reaction (PCR), fluorescence detection |
| Sample material | Faeces |
| Instrument information | Sample lysis, dilution, amplification, detection and results interpretation in the Revogene® instrument, inside the cartridge (pie) |
| Sensitivity | 96 % |
| Specificity | 90 % |
| Hands on time | < 2 minutes |
| Results | < 70 minutes, Early Positive Result Outcome (E-PRO) 42 minutes |
| Storage | 2–25 °C |
| Other material needed | Vortex mixer |
| Registered trademark | Revogene® is a registered trademark of Meridian Bioscience, Inc. |
More information
Visit website: Revogene® GBS DS | Meridian Bioscience